REPORTS ON BRUCELIOSIS REPRESENTED AT SESSION OF ACADEMY OF MEDICAL SCIENCES USSR

Document Type: 
Collection: 
Document Number (FOIA) /ESDN (CREST): 
CIA-RDP80-00809A000700230130-0
Release Decision: 
RIPPUB
Original Classification: 
U
Document Page Count: 
3
Document Creation Date: 
December 22, 2016
Document Release Date: 
July 12, 2011
Sequence Number: 
130
Case Number: 
Publication Date: 
June 1, 1955
Content Type: 
REPORT
File: 
AttachmentSize
PDF icon CIA-RDP80-00809A000700230130-0.pdf105.21 KB
Body: 
Sanitized Copy Approved for Release 2011/07/14: CIA-RDP80-00809A000700230130-0 STAT Sanitized Copy Approved for Release 2011/07/14: CIA-RDP80-00809A000700230130-0 Sanitized Copy Approved for Release 2011/07/14: CIA-RDP80-00809A000700230130-0 REPORTS OH BRUCELLOSIS OF ACADEMY OF FRESENTEI AT SESSION Meditsinski Rabotnik, Vol 17, No 81 (1305) Moscow, Oct 19 The scientific session [called by the Academy of Medical Sciences USSR andubjectedthe Ministryy to ofsidedHealth Uzbek SSR and held in Tashkent 20-25 September 1954] man S discussion the complex problems connected with the control of brucellosis, which are of great importance from the standpoint of cussed and public health. Problems pertaining to the a idemiolo nical censd inclinicas aspects, prophylaxis, and therapy c s ~, Pdiho- Y Prof G. P. Rudnev, Active Member of Medical Sciences USSR; prof T. Kh. N of the Academy adzhimiddinov; Prof I. K. Karakulov, Corresponding Member of The Academy of Sciences Kazakh SSR; and Kh. A. Yunu- sova (Tashkent), Candidate of Medical Sciences. After pointing out that there has been definite progress in the pro- phylaxis and therapy of brucellosis, the authors of the reports stated that Physicians must carefully consider all epidemiological factors when they diagnose this disease. The therapy of brucellosis, which must be specific and adapted to the pathogenesis of the disease [rather than symptomatic], should correspond in all its stages to the particular Pecific and to the condition of the organism. YmPt?matic], concerned, the recently modified method Aoffinoculationptherapyr(intrave ous inoculation in two stages), the application of a number of new antibiotics X-ray therapy, and electropyrexia are most effective. The participants in the session listened with interest to the papers by Docent Sh. Kh. Khodzhayev (Tashkent) and D. G. Babayev (Baku) dealing with quantitative and qualitative changes in the peripheral blood and in the bone marrow due to brucellosis, as well as with organic afflictions of the cardio- vascular system, particularly the endocardium and the aortal ,alves. Since clinical aspects of brucellar endocarditis resemble those of septic endocardi- tie, it is necessary to revise the views concerning the etiology of the lat- ter. Assistant Z. Ya. Abdullakhodzhayev (Stalinabad) related experience in the treatment of chronic and subacute forms of brucellosis with the aid of a new and merciful method of electropyrexia (production of artificial fever in patients who do not have a raised temperature). Prof 0. D. Sokolova-ponomareva, Corresponding Member of the Academy of Medical Sciences USSR, described in detail the characteristics of the clinical course of brucellosis in children. Brucellosis in children is distinguished by a definite polymorphism, various afflications of the skin (rashes) and of the lymphatic system, vascular insufficiency, and gastrointestinal disturbances (dyspepsia and colites). In addition to inoculation therapy and the applica- tion of antibiotics, complete and effective treatment must include good care, good naa-ishment, and administration of vitamin C. Prof Z. V. Yermol'yeva, Corresponding Member of the Academy of Medical Sciences USSR, reported on the results of a clinical investigation of the therapeutic effectiveness of antibiotics. According to Yermol' results were obtained by applying biomycin and terramycin in combination with the brucellosis vaccine. Yeva, the best Sanitized Copy Approved for Release 2011/07/14: CIA-RDP80-00809A000700230130-0 Sanitized Copy Approved for Release 2011/07/14: CIA-RDP80-00809A000700230130-0 However, as has been pointed out in a report by Prof A. F. Bilibin, Cor- responding Member of the Academ f M y o edical Sciences USSR, it is an error to assume that the application of antibiotics has opened a new era in the therapy of brucellosis. The therapy of this disease still remains as difficult and complex as it was before. one cannot assert that some method or preparation is preferable to others, because the success of any method of treatment depends on the stage and period of the disease at which treatment has been begun. Syn- thomycin and streptomycin must undoubtedly be replaced by levomycetin and blo- mycin. The effectiveness of antibiotics can be improved by applying them to- gether with the vaccine at the stage of the disease during which the causative factor plays the principal role. M. M. Rementsova, Candidate of Biological Sciences (Kazakh SSR), raised the interesting question in regard to the zoonotic factor in the epidemiology of brucellosis. After pointing out that Prof Karakulov in his report almost failed to touch on the problem of the natural reservoirs of brucellosis, she expressed the opinion that one cannot regard farm animals as the principal and only reservoir of brucellosis infection. Many cases of the reappearance of brucellosis at farms after its complete elimination there have been recorded. Observations have confirmed that blood-sucking ticks, rodents of the mouse family, and wild, hoofed animals are carriers and transmitters of the brucellosis infection. The problem of the natural reservoirs of brucellosis requires further study. The experience which has been acquired in the prevention and treatment of brucellosis, particularly as far as elimination of reservoirs and immunization of human beings are concerned, enables us to raise at this point the question of the complete elimination of this disease, especially in the areas of the country where animal husbandry plays an important role. Sanitized Copy Approved for Release 2011/07/14: CIA-RDP80-00809A000700230130-0